Organigram Strives For ‘High Potency Cannabinoid’ With $6M Phylos Investment
Organigram invests $6 million in Phylos for cannabis genetics innovation, new cannabinoid products and future U.S. market expansion.
‘Consumers Expect More From Cannabis Producers’: Organigram Unveils THCV Products From Exclusive Genetics
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has introduced its inaugural line of THCV products under the SHRED and Trailblazer brands.
The company has invested strategically in Phylos Bioscience, a leading US-based cannabis genetics company to secure a competitive edge in the cannabis sector.
Organigram Invests In Phylos Bioscience To Commercialize THCV And Scale Seed Based Production
Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has reached agreement with Phylos Bioscience Inc., to initiate a wide-ranging technical and commercial relationship in Canada.